06:03 PM EDT, 08/29/2024 (MT Newswires) -- ARCA Biopharma ( ABIO ) said late Thursday that it completed its merger with Oruka Therapeutics following a stockholder approval at a special meeting on Aug. 22.

In addition, the combined company will implement a reverse stock split at a ratio of 1-for-12 shares, the company said.

The combined company will operate under Oruka Therapeutics, with shares to begin trading on a post-reverse split on Nasdaq under the ORKA ticker symbol from Sept. 3.

Price: 2.5500, Change: +0.05, Percent Change: +2.00